[1]
“Evaluation of Interleukin-6 Levels in Patients with Type 2 Diabetes Mellitus”, IAHS Med. J., vol. 6, no. 2, pp. 53–57, Sep. 2024, doi: 10.3329/iahsmj.v6i2.76095.